171 related articles for article (PubMed ID: 37349822)
21. Cost-effectiveness of cervical cancer screening methods in low- and middle-income countries: A systematic review.
Mezei AK; Armstrong HL; Pedersen HN; Campos NG; Mitchell SM; Sekikubo M; Byamugisha JK; Kim JJ; Bryan S; Ogilvie GS
Int J Cancer; 2017 Aug; 141(3):437-446. PubMed ID: 28297074
[TBL] [Abstract][Full Text] [Related]
22. A systematic review and meta-analysis of diagnostic accuracy of HPV tests for the screening of cervical cancer in low-resource settings.
Magdi R; Elshafeey F; Elshebiny M; Kamel M; Abuelnaga Y; Ghonim M; Nabhan A;
Int J Gynaecol Obstet; 2021 Jan; 152(1):12-18. PubMed ID: 33124048
[TBL] [Abstract][Full Text] [Related]
23. Acting on the call for cervical cancer elimination: Planning tools for low- and middle- income countries to increase the coverage and effectiveness of screening and treatment.
Herrick T; Thomson KA; Shin M; Gannon S; Tsu V; de Sanjosé S
BMC Health Serv Res; 2022 Oct; 22(1):1246. PubMed ID: 36241993
[TBL] [Abstract][Full Text] [Related]
24. Study protocol of the ACCESS trial: a randomised trial to evaluate the effectiveness of human papillomavirus testing by self-sampling in cervical cancer screening uptake and precancer detection.
Fujita M; Shimazu M; Nagashima K; Suzuki M; Tauchi I; Sakuma M; Yamamoto S; Shozu M; Hanaoka H; Tsuruoka N; Kasai T; Hata A
BMJ Open; 2022 Feb; 12(2):e049803. PubMed ID: 35115348
[TBL] [Abstract][Full Text] [Related]
25. Uptake of community-based, self-collected HPV testing vs. visual inspection with acetic acid for cervical cancer screening in Kampala, Uganda: preliminary results of a randomised controlled trial.
Moses E; Pedersen HN; Mitchell SM; Sekikubo M; Mwesigwa D; Singer J; Biryabarema C; Byamugisha JK; Money DM; Ogilvie GS
Trop Med Int Health; 2015 Oct; 20(10):1355-67. PubMed ID: 26031572
[TBL] [Abstract][Full Text] [Related]
26. Cost-effectiveness of an HPV self-collection campaign in Uganda: comparing models for delivery of cervical cancer screening in a low-income setting.
Campos NG; Tsu V; Jeronimo J; Njama-Meya D; Mvundura M; Kim JJ
Health Policy Plan; 2017 Sep; 32(7):956-968. PubMed ID: 28369405
[TBL] [Abstract][Full Text] [Related]
27. Effect of Mailed Human Papillomavirus Test Kits vs Usual Care Reminders on Cervical Cancer Screening Uptake, Precancer Detection, and Treatment: A Randomized Clinical Trial.
Winer RL; Lin J; Tiro JA; Miglioretti DL; Beatty T; Gao H; Kimbel K; Thayer C; Buist DSM
JAMA Netw Open; 2019 Nov; 2(11):e1914729. PubMed ID: 31693128
[TBL] [Abstract][Full Text] [Related]
28. High-risk HPV testing on self-sampled versus clinician-collected specimens: a review on the clinical accuracy and impact on population attendance in cervical cancer screening.
Snijders PJ; Verhoef VM; Arbyn M; Ogilvie G; Minozzi S; Banzi R; van Kemenade FJ; Heideman DA; Meijer CJ
Int J Cancer; 2013 May; 132(10):2223-36. PubMed ID: 22907569
[TBL] [Abstract][Full Text] [Related]
29. Acceptability and Feasibility of HPV Self-Sampling as an Alternative Primary Cervical Cancer Screening in Under-Screened Population Groups: A Cross-Sectional Study.
Wong EL; Cheung AW; Wong AY; Chan PK
Int J Environ Res Public Health; 2020 Aug; 17(17):. PubMed ID: 32867315
[No Abstract] [Full Text] [Related]
30. Preferred Location for Human Papillomavirus Self-Sampling for Cervical Cancer Screening.
Liebermann E; Fontenot HB; Lim E; Matsunaga M; Zimet G; Allen JD
J Obstet Gynecol Neonatal Nurs; 2023 Sep; 52(5):364-373. PubMed ID: 37355248
[TBL] [Abstract][Full Text] [Related]
31. Comparison between self sampling and provider collected samples for Human Papillomavirus (HPV) Deoxyribonucleic acid (DNA) testing in a Nigerian facility.
Ajenifuja OK; Ikeri NZ; Adeteye OV; Banjo AA
Pan Afr Med J; 2018; 30():110. PubMed ID: 30364362
[TBL] [Abstract][Full Text] [Related]
32. A systematic review of economic evaluations of cervical cancer screening methods.
Sefuthi T; Nkonki L
Syst Rev; 2022 Aug; 11(1):162. PubMed ID: 35945642
[TBL] [Abstract][Full Text] [Related]
33. Acceptability of HPV screening among HIV-infected women attending an HIV-dedicated clinic in Abidjan, Côte d'Ivoire.
Mensah K; Assoumou N; Duchesne V; Pourette D; DeBeaudrap P; Dumont A
BMC Womens Health; 2020 Jul; 20(1):155. PubMed ID: 32723350
[TBL] [Abstract][Full Text] [Related]
34. Screening for cancer in low- and middle-income countries.
Sankaranarayanan R
Ann Glob Health; 2014; 80(5):412-7. PubMed ID: 25512156
[TBL] [Abstract][Full Text] [Related]
35. Integrated cervical cancer screening in Mayuge District Uganda (ASPIRE Mayuge): a pragmatic sequential cluster randomized trial protocol.
Nakisige C; Trawin J; Mitchell-Foster S; Payne BA; Rawat A; Mithani N; Amuge C; Pedersen H; Orem J; Smith L; Ogilvie G
BMC Public Health; 2020 Jan; 20(1):142. PubMed ID: 32005202
[TBL] [Abstract][Full Text] [Related]
36. Acceptability and feasibility of self-sampling and follow-up attendance after text message delivery of human papillomavirus results: A cross-sectional study nested in a cohort in rural Tanzania.
Mremi A; Linde DS; Mchome B; Mlay J; Schledermann D; Blaakaer J; Rasch V
Acta Obstet Gynecol Scand; 2021 Apr; 100(4):802-810. PubMed ID: 33555038
[TBL] [Abstract][Full Text] [Related]
37. Prevalence and sociodemographic predictors of high-risk vaginal human papillomavirus infection: findings from a public cervical cancer screening registry.
Jailani AS; Balqis-Ali NZ; Tang KF; Fun WH; Samad SA; Jahaya R; Subakir NN; Ismail R; Said ZM; Sararaks S
BMC Public Health; 2023 Nov; 23(1):2243. PubMed ID: 37964260
[TBL] [Abstract][Full Text] [Related]
38. Integrating HPV vaccination programs with enhanced cervical cancer screening and treatment, a systematic review.
Wirtz C; Mohamed Y; Engel D; Sidibe A; Holloway M; Bloem P; Kumar S; Brotherton J; Reis V; Morgan C
Vaccine; 2022 Mar; 40 Suppl 1():A116-A123. PubMed ID: 34863615
[TBL] [Abstract][Full Text] [Related]
39. Muslim immigrant women's views on cervical cancer screening and HPV self-sampling in Ontario, Canada.
Vahabi M; Lofters A
BMC Public Health; 2016 Aug; 16(1):868. PubMed ID: 27557928
[TBL] [Abstract][Full Text] [Related]
40. Cytology versus HPV testing for cervical cancer screening in the general population.
Koliopoulos G; Nyaga VN; Santesso N; Bryant A; Martin-Hirsch PP; Mustafa RA; Schünemann H; Paraskevaidis E; Arbyn M
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD008587. PubMed ID: 28796882
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
